Skip to content

Reversibility of Diastolic Disfunction in Septic Shock

Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03198611
Acronym
REPRISS
Enrollment
350
Registered
2017-06-26
Start date
2018-03-01
Completion date
2019-04-01
Last updated
2018-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diastolic Dysfunction, Septic Shock

Brief summary

Objectives: To study the prognostic value of the evolution of diastolic function according to fluid balance in patients admitted to the ICU with a diagnosis of septic shock, in terms of mortality (ICU and hospital) and mortality at 90 days. 2.4. Secondary objectives: A) Incidence and reversibility of myocardial dysfunction (left ventricular systolic and diastolic) in septic shock. B) Incidence and reversibility of diastolic dysfunction according to the echocardiographic criterion used. C) Incidence and reversibility of right ventricular systolic dysfunction.

Interventions

DIAGNOSTIC_TESTEchocardiography

Usual echocardiographic studies in patients suffering septic shock

Sponsors

Spanish Clinical Research Network - SCReN
CollaboratorNETWORK
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the ICU with diagnosis of septic shock, and stay longer than 48h

Exclusion criteria

* No echocardiographic window * Fatal prognosis with do not resuscitate orders at admission * Previous history of Ischemic cardiomyopathy * Valvular prosthesis * Advanced degree of valvular disorder * Advanced degree of pericardial effusion

Design outcomes

Primary

MeasureTime frameDescription
Mortality at 90 days90 daysDead at 90 days

Secondary

MeasureTime frameDescription
ICU mortality90 daysDead in ICU
In hospital mortality90 daysDead in hospital
Incidence of myocardial disfunctionDuring the first 24 hours of ICU admissionAccording to the criteria specified at groups section
Change in incidence of diastolic dysfunctionFrom first 24 hours of ICU admission until 48h, 72h and 7 days from admissionChange in incidence of diastolic dysfunction according to the different criteria used.

Countries

Spain

Contacts

Primary ContactLuis Zapata Fenor, MD PhD
LZapata@santpau.cat0034935537255

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026